Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia

Vanessa Klapp; Jerome Paggetti; Anne Largeot; Etienne Moussay

doi:10.1002/cac2.12493

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia

Vanessa Klapp, Jerome Paggetti^*, Anne Largeot^*, Etienne Moussay^*

^*Corresponding author for this work

Tumor Stroma Interactions

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Journal	Cancer Communications
Early online date	6 Oct 2023
DOIs	https://doi.org/10.1002/cac2.12493
Publication status	E-pub ahead of print - 6 Oct 2023

Access to Document

10.1002/cac2.12493Licence: CC BY-NC-ND

Cite this

@article{1432dddd8bd34322af19998a10ae458f,

title = "Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia",

author = "Vanessa Klapp and Jerome Paggetti and Anne Largeot and Etienne Moussay",

note = "Funding Information: This work was supported by grants from the Luxembourg National Research Fund (FNR) and Fondation Cancer to Vanessa Klapp, Etienne Moussay, J{\'e}r{\^o}me Paggetti (PRIDE19/14254520/i2TRON, C20/BM/14582635, and C20/BM/14592342), from FNRS‐T{\'e}l{\'e}vie to Anne Largeot (7.4502.17, 7.4503.19), and from the Plooschter Projet to J{\'e}r{\^o}me Paggetti and Etienne Moussay. ",

year = "2023",

month = oct,

day = "6",

doi = "10.1002/cac2.12493",

language = "English",

journal = "Cancer Communications",

issn = "1000-467X",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Targeting mRNA translation aberrations

T2 - A novel approach for therapy in chronic lymphocytic leukemia

AU - Klapp, Vanessa

AU - Paggetti, Jerome

AU - Largeot, Anne

AU - Moussay, Etienne

N1 - Funding Information: This work was supported by grants from the Luxembourg National Research Fund (FNR) and Fondation Cancer to Vanessa Klapp, Etienne Moussay, Jérôme Paggetti (PRIDE19/14254520/i2TRON, C20/BM/14582635, and C20/BM/14592342), from FNRS‐Télévie to Anne Largeot (7.4502.17, 7.4503.19), and from the Plooschter Projet to Jérôme Paggetti and Etienne Moussay.

PY - 2023/10/6

Y1 - 2023/10/6

UR - http://www.scopus.com/inward/record.url?scp=85173546946&partnerID=8YFLogxK

UR - https://pubmed.ncbi.nlm.nih.gov/37803910

U2 - 10.1002/cac2.12493

DO - 10.1002/cac2.12493

M3 - Article

C2 - 37803910

SN - 1000-467X

JO - Cancer Communications

JF - Cancer Communications

ER -

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia

Access to Document

Other files and links

Cite this